These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26082101)

  • 21. Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Carmona F; Casamitjana R; Vanrell JA; Balasch J
    Hum Reprod; 2005 Mar; 20(3):622-8. PubMed ID: 15608035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of androgens and multivariate model for poor ovarian response.
    Guo J; Zhang Q; Li Y; Huang J; Wang W; Huang L; Zhao X; Yang D
    Reprod Biomed Online; 2014 Jun; 28(6):723-32. PubMed ID: 24745840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
    Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Falling FSH levels predict poor IVF pregnancy rates in patients whom the gonadotropins are withheld.
    Erman Akar M; Oktay K
    Arch Gynecol Obstet; 2009 Nov; 280(5):761-5. PubMed ID: 19255769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can the fall in serum FSH during coasting in IVF/ICSI predict clinical outcomes?
    Datta AK; Zosmer A; Tozer A; Sabatini L; Davis C; Al-Shawaf T
    Reprod Biomed Online; 2012 May; 24(5):503-10. PubMed ID: 22417663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of theca cell function prior to controlled ovarian stimulation: the predictive value of serum basal/stimulated steroid levels.
    Hugues JN; Theron-Gerard L; Coussieu C; Pasquier M; Dewailly D; Cedrin-Durnerin I
    Hum Reprod; 2010 Jan; 25(1):228-34. PubMed ID: 19897528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated day 3 follicle-stimulating hormone in younger women: is gonadotropin stimulation/intrauterine insemination a good option?
    Souter I; Dimitriadis I; Baltagi LM; Meeker JD; Petrozza JC
    Am J Obstet Gynecol; 2014 Jul; 211(1):62.e1-8. PubMed ID: 24487006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF.
    Erdem M; Erdem A; Gursoy R; Biberoglu K
    J Assist Reprod Genet; 2004 Feb; 21(2):37-45. PubMed ID: 15186020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective analysis of ovarian reserve markers as determinant in response to controlled ovarian stimulation in women undergoing IVF cycles in low resource setting in India.
    Singh N; Bahadur A; Malhotra N; Kalaivani M; Mittal S
    Arch Gynecol Obstet; 2013 Sep; 288(3):697-703. PubMed ID: 23529683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among Chinese couples.
    Zhen XM; Qiao J; Li R; Wang LN; Liu P
    J Assist Reprod Genet; 2008 Jan; 25(1):17-22. PubMed ID: 18202912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy.
    Srebnik N; Margalioth EJ; Rabinowitz R; Varshaver I; Altarescu G; Renbaum P; Levi-Lahad E; Weintraub A; Eldar-Geva T
    Reprod Biomed Online; 2014 Jul; 29(1):94-101. PubMed ID: 24813161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of age-related changes in anti-Müllerian hormone levels and other ovarian reserve tests between healthy fertile and infertile population.
    Bozkurt B; Erdem M; Mutlu MF; Erdem A; Guler I; Mutlu I; Oktem M
    Hum Fertil (Camb); 2016 Sep; 19(3):192-8. PubMed ID: 27499425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level.
    Hendriks DJ; Mol BW; Bancsi LF; Te Velde ER; Broekmans FJ
    Fertil Steril; 2005 Feb; 83(2):291-301. PubMed ID: 15705365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The probability of successful IVF outcome after poor ovarian response.
    Saldeen P; Källen K; Sundström P
    Acta Obstet Gynecol Scand; 2007; 86(4):457-61. PubMed ID: 17486468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical applications of different doses of leuprorelin acetate in in vitro fertilization-embryo transfer].
    Wang L; Zhang WX; Jiang H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):910-4. PubMed ID: 23324190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimullerian hormone in cases of different reproductive pathologies.
    Barbakadze L; Kristasashvili J
    Georgian Med News; 2014; (232-233):16-21. PubMed ID: 25214265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.